Global Congenital Heart Diseases Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 108 pages | ID: G33D21D19FDEN
GlobalInfoResearch

Abstracts

Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with breathing and circulation disorders. According to Lancet medical journal, CHD caused death of 0.22 million individuals and newborns globally in the year 2010. CHD was earlier erroneously associated with premature births, the association has no direct correlation with all forms of CHD and is mainly one of the many factors that can cause it. The genetic factors causing CHD consist of chromosomal errors in fertilization and the following meiotic division, these include: large chromosomal defects in trisomal chromosomes; small chromosomal defects like microdeletion of long/short arm of chromosome and random/environmentally induced mutation of heart muscle cell proteins, or associated proteins etc. The environmental factors like rubella infections, thalidomide drugs, metals (lithium, lead, mercury, etc), chronic illness in the mother (systemic lupus, diabetes, phenylketonuria, etc). Embryological changes, hormonal changes in the mother and certain birth deficiencies can also cause CHD and other birth defects in children. Besides these, according to some medical research reports, maternal obesity increased the chances of CHD in newborns; obesity was shown to increase the risk of previously hidden genetic traits of CHD in the new born children of such obese mothers.

SCOPE OF THE REPORT:

This report studies the Congenital Heart Diseases market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Congenital Heart Diseases market by product type and applications/end industries.
The treatment of CHD varies from case to case; genetic testing/screening is mandatory in case the doctor suspects a genetic cause for the disease, in developed countries this is done for all newborns. The next step would be surgery or drug treatment, again this depends upon the severity of the condition. In most cases CHD presents itself as serious conditions with high risk of complications, hence surgery is the most followed procedure. In certain disorders like ASD a pediatric surgeon may ask the parents of a CHD child to wait for the child?s growth as ASD is known to disappear gradually, a surgery is performed if ASD persists after the child?s growth. Certain cases also require multiple surgeries and stenting in order to restore a malformed tract in the lungs, etc. Drugs like diuretics are given to regulate vasoconstriction that alleviates deoxygenation and helps remove toxins from the body, besides reducing the heartbeat.
The global Congenital Heart Diseases market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Congenital Heart Diseases.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Pfizer
• Abbott Laboratories
• Eli Lilly
• Ranbaxy Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Hypoplasia
• Obstructive
• Septal Defects

Market Segment by Applications, can be divided into

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

Contents

1 CONGENITAL HEART DISEASES MARKET OVERVIEW

1.1 Product Overview and Scope of Congenital Heart Diseases
1.2 Classification of Congenital Heart Diseases by Types
  1.2.1 Global Congenital Heart Diseases Revenue Comparison by Types (2017-2023)
  1.2.2 Global Congenital Heart Diseases Revenue Market Share by Types in 2017
  1.2.3 Hypoplasia
  1.2.4 Obstructive
  1.2.5 Septal Defects
1.3 Global Congenital Heart Diseases Market by Application
  1.3.1 Global Congenital Heart Diseases Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Diagnostic Centers
  1.3.5 Others
1.4 Global Congenital Heart Diseases Market by Regions
  1.4.1 Global Congenital Heart Diseases Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Congenital Heart Diseases Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Congenital Heart Diseases Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Congenital Heart Diseases Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Congenital Heart Diseases Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Congenital Heart Diseases Status and Prospect (2013-2023)
1.5 Global Market Size of Congenital Heart Diseases (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Congenital Heart Diseases Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
  2.2.1 Business Overview
  2.2.2 Congenital Heart Diseases Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Abbott Laboratories Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
  2.3.1 Business Overview
  2.3.2 Congenital Heart Diseases Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Eli Lilly Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ranbaxy Pharmaceutical
  2.4.1 Business Overview
  2.4.2 Congenital Heart Diseases Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Ranbaxy Pharmaceutical Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CONGENITAL HEART DISEASES MARKET COMPETITION, BY PLAYERS

3.1 Global Congenital Heart Diseases Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Congenital Heart Diseases Players Market Share
  3.2.2 Top 10 Congenital Heart Diseases Players Market Share
3.3 Market Competition Trend

4 GLOBAL CONGENITAL HEART DISEASES MARKET SIZE BY REGIONS

4.1 Global Congenital Heart Diseases Revenue and Market Share by Regions
4.2 North America Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
4.3 Europe Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
4.5 South America Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CONGENITAL HEART DISEASES REVENUE BY COUNTRIES

5.1 North America Congenital Heart Diseases Revenue by Countries (2013-2018)
5.2 USA Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
5.3 Canada Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
5.4 Mexico Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

6 EUROPE CONGENITAL HEART DISEASES REVENUE BY COUNTRIES

6.1 Europe Congenital Heart Diseases Revenue by Countries (2013-2018)
6.2 Germany Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
6.3 UK Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
6.4 France Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
6.5 Russia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
6.6 Italy Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CONGENITAL HEART DISEASES REVENUE BY COUNTRIES

7.1 Asia-Pacific Congenital Heart Diseases Revenue by Countries (2013-2018)
7.2 China Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
7.3 Japan Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
7.4 Korea Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
7.5 India Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CONGENITAL HEART DISEASES REVENUE BY COUNTRIES

8.1 South America Congenital Heart Diseases Revenue by Countries (2013-2018)
8.2 Brazil Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
8.3 Argentina Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
8.4 Colombia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CONGENITAL HEART DISEASES BY COUNTRIES

9.1 Middle East and Africa Congenital Heart Diseases Revenue by Countries (2013-2018)
9.2 Saudi Arabia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
9.3 UAE Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
9.4 Egypt Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
9.5 Nigeria Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
9.6 South Africa Congenital Heart Diseases Revenue and Growth Rate (2013-2018)

10 GLOBAL CONGENITAL HEART DISEASES MARKET SEGMENT BY TYPE

10.1 Global Congenital Heart Diseases Revenue and Market Share by Type (2013-2018)
10.2 Global Congenital Heart Diseases Market Forecast by Type (2018-2023)
10.3 Hypoplasia Revenue Growth Rate (2013-2023)
10.4 Obstructive Revenue Growth Rate (2013-2023)
10.5 Septal Defects Revenue Growth Rate (2013-2023)

11 GLOBAL CONGENITAL HEART DISEASES MARKET SEGMENT BY APPLICATION

11.1 Global Congenital Heart Diseases Revenue Market Share by Application (2013-2018)
11.2 Congenital Heart Diseases Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)

12 GLOBAL CONGENITAL HEART DISEASES MARKET SIZE FORECAST (2018-2023)

12.1 Global Congenital Heart Diseases Market Size Forecast (2018-2023)
12.2 Global Congenital Heart Diseases Market Forecast by Regions (2018-2023)
12.3 North America Congenital Heart Diseases Revenue Market Forecast (2018-2023)
12.4 Europe Congenital Heart Diseases Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Congenital Heart Diseases Revenue Market Forecast (2018-2023)
12.6 South America Congenital Heart Diseases Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Congenital Heart Diseases Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Congenital Heart Diseases Picture
Table Product Specifications of Congenital Heart Diseases
Table Global Congenital Heart Diseases and Revenue (Million USD) Market Split by Product Type
Figure Global Congenital Heart Diseases Revenue Market Share by Types in 2017
Figure Hypoplasia Picture
Figure Obstructive Picture
Figure Septal Defects Picture
Table Global Congenital Heart Diseases Revenue (Million USD) by Application (2013-2023)
Figure Congenital Heart Diseases Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Figure Others Picture
Table Global Market Congenital Heart Diseases Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Congenital Heart Diseases Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Congenital Heart Diseases Type and Applications
Table Pfizer Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Congenital Heart Diseases Type and Applications
Table Abbott Laboratories Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Congenital Heart Diseases Type and Applications
Table Eli Lilly Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Ranbaxy Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Pharmaceutical Congenital Heart Diseases Type and Applications
Table Ranbaxy Pharmaceutical Congenital Heart Diseases Revenue, Gross Margin and Market Share (2016-2017)
Table Global Congenital Heart Diseases Revenue (Million USD) by Players (2013-2018)
Table Global Congenital Heart Diseases Revenue Share by Players (2013-2018)
Figure Global Congenital Heart Diseases Revenue Share by Players in 2016
Figure Global Congenital Heart Diseases Revenue Share by Players in 2017
Figure Global Top 5 Players Congenital Heart Diseases Revenue Market Share in 2017
Figure Global Top 10 Players Congenital Heart Diseases Revenue Market Share in 2017
Figure Global Congenital Heart Diseases Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Congenital Heart Diseases Revenue (Million USD) by Regions (2013-2018)
Table Global Congenital Heart Diseases Revenue Market Share by Regions (2013-2018)
Figure Global Congenital Heart Diseases Revenue Market Share by Regions (2013-2018)
Figure Global Congenital Heart Diseases Revenue Market Share by Regions in 2017
Figure North America Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Europe Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure South America Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table North America Congenital Heart Diseases Revenue by Countries (2013-2018)
Table North America Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure North America Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure North America Congenital Heart Diseases Revenue Market Share by Countries in 2017
Figure USA Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Canada Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Mexico Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table Europe Congenital Heart Diseases Revenue (Million USD) by Countries (2013-2018)
Figure Europe Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure Europe Congenital Heart Diseases Revenue Market Share by Countries in 2017
Figure Germany Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure UK Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure France Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Russia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Italy Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Congenital Heart Diseases Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Congenital Heart Diseases Revenue Market Share by Countries in 2017
Figure China Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Japan Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Korea Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure India Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table South America Congenital Heart Diseases Revenue by Countries (2013-2018)
Table South America Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure South America Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure South America Congenital Heart Diseases Revenue Market Share by Countries in 2017
Figure Brazil Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Argentina Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Colombia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Congenital Heart Diseases Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Congenital Heart Diseases Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Congenital Heart Diseases Revenue Market Share by Countries in 2017
Figure Saudi Arabia Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure UAE Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Egypt Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure Nigeria Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Figure South Africa Congenital Heart Diseases Revenue and Growth Rate (2013-2018)
Table Global Congenital Heart Diseases Revenue (Million USD) by Type (2013-2018)
Table Global Congenital Heart Diseases Revenue Share by Type (2013-2018)
Figure Global Congenital Heart Diseases Revenue Share by Type (2013-2018)
Figure Global Congenital Heart Diseases Revenue Share by Type in 2017
Table Global Congenital Heart Diseases Revenue Forecast by Type (2018-2023)
Figure Global Congenital Heart Diseases Market Share Forecast by Type (2018-2023)
Figure Global Hypoplasia Revenue Growth Rate (2013-2018)
Figure Global Obstructive Revenue Growth Rate (2013-2018)
Figure Global Septal Defects Revenue Growth Rate (2013-2018)
Table Global Congenital Heart Diseases Revenue by Application (2013-2018)
Table Global Congenital Heart Diseases Revenue Share by Application (2013-2018)
Figure Global Congenital Heart Diseases Revenue Share by Application (2013-2018)
Figure Global Congenital Heart Diseases Revenue Share by Application in 2017
Table Global Congenital Heart Diseases Revenue Forecast by Application (2018-2023)
Figure Global Congenital Heart Diseases Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Congenital Heart Diseases Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Congenital Heart Diseases Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Congenital Heart Diseases Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Congenital Heart Diseases Revenue Market Forecast (2018-2023)
Figure Europe Congenital Heart Diseases Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Congenital Heart Diseases Revenue Market Forecast (2018-2023)
Figure South America Congenital Heart Diseases Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Congenital Heart Diseases Revenue Market Forecast (2018-2023)